GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viela Bio Inc (NAS:VIE) » Definitions » Inventory Turnover

Viela Bio (Viela Bio) Inventory Turnover : 3.17 (As of Dec. 2020)


View and export this data going back to 2019. Start your Free Trial

What is Viela Bio Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Viela Bio's Cost of Goods Sold for the three months ended in Dec. 2020 was $1.39 Mil. Viela Bio's Average Total Inventories for the quarter that ended in Dec. 2020 was $0.44 Mil. Viela Bio's Inventory Turnover for the quarter that ended in Dec. 2020 was 3.17.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Viela Bio's Days Inventory for the three months ended in Dec. 2020 was 28.75.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Viela Bio's Inventory-to-Revenue for the quarter that ended in Dec. 2020 was 0.05.

Viela Bio Inventory Turnover Historical Data

The historical data trend for Viela Bio's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viela Bio Inventory Turnover Chart

Viela Bio Annual Data
Trend Dec18 Dec19 Dec20
Inventory Turnover
- - -

Viela Bio Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.48 3.17

Viela Bio Inventory Turnover Calculation

Viela Bio's Inventory Turnover for the fiscal year that ended in Dec. 2020 is calculated as

Inventory Turnover (A: Dec. 2020 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2020 ) / ((Total Inventories (A: Dec. 2019 ) + Total Inventories (A: Dec. 2020 )) / count )
=2.04 / ((0 + 0) / 1 )
=2.04 / 0
=N/A

Viela Bio's Inventory Turnover for the quarter that ended in Dec. 2020 is calculated as

Inventory Turnover (Q: Dec. 2020 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Dec. 2020 ) / ((Total Inventories (Q: Sep. 2020 ) + Total Inventories (Q: Dec. 2020 )) / count )
=1.39 / ((0.438 + 0) / 1 )
=1.39 / 0.438
=3.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viela Bio  (NAS:VIE) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Viela Bio's Days Inventory for the three months ended in Dec. 2020 is calculated as:

Days Inventory =Average Total Inventories (Q: Dec. 2020 )/Cost of Goods Sold (Q: Dec. 2020 )*Days in Period
=0.438/1.39*365 / 4
=28.75

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Viela Bio's Inventory to Revenue for the quarter that ended in Dec. 2020 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2020 ) / Revenue (Q: Dec. 2020 )
=0.438 / 9.336
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Viela Bio Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Viela Bio's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Viela Bio (Viela Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viela Bio Inc (NAS:VIE) » Definitions » Inventory Turnover
Comparable Companies
FOLD FGEN DCPH PTCT HALO ARNA AXSM QURE NVAX ARWR OCSE:NOVO B ASX:CSL VRTX REGN XKRX:207940 SGEN MRNA ALXN XKRX:068270 INCY
Traded in Other Exchanges
N/A
Address
One MedImmune Way, First Floor, Area Two, Gaithersburg, MD, USA, 20878
Website
https://www.vielabio.com
Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.
Executives
Chris Nolet director C/O REVANCE THERAPEUTICS, INC., 7555 GATEWAY BOULEVARD, NEWARK CA 94560
Rachelle Suzanne Jacques director C/O CORBUS PHARMACEUTICALS HOLDINGS, INC, 100 RIVER RIDGE DRIVE, NORWOOD MA 02062
Edward Hu director 10975 TORREY PINES ROAD, LA JOLLA CA 92037
Boyu Capital General Partner Iii, L.p. 10 percent owner SUITE 1518, TWO PACIFIC PLACE 88 QUEENSWAY HONG KONG K3 00000
Boyu Capital General Partner Iii, Ltd. 10 percent owner SUITE 1518, TWO PACIFIC PLACE 88 QUEENSWAY HONG KONG K3 00000
Boyu Capital Group Holdings Ltd. 10 percent owner SUITE 1518, TWO PACIFIC PLACE 88 QUEENSWAY HONG KONG K3 00000
Xyxy Holdings Ltd. 10 percent owner SUITE 1518, TWO PACIFIC PLACE 88 QUEENSWAY HONG KONG K3 00000
Boyu Capital Investment Management Ltd 10 percent owner SUITE 1501, TWO PACIFIC PLACE 88 QUEENSWAY HONG KONG K3 00000
Boundless Meadow Ltd 10 percent owner SUITE 1518, TWO PACIFIC PLACE 88 QUEENSWAY HONG KONG K3 00000
Xiaomeng Tong director, 10 percent owner SUITE 1518, TWO PACIFIC PLACE 88 QUEENSWAY HONG KONG K3 00000
Yanling Cao director, 10 percent owner SUITE 1518, TWO PACIFIC PLACE 88 QUEENSWAY HONG KONG K3 00000
Boyu Capital Fund Iii, L.p. 10 percent owner C/O MAPLES CORPORATE SERVICES LIMITED BOX 309, UGLAND HOUSE GRAND CAYMAN E9 KYL-1104
Boyu Capital Opportunities Master Fund 10 percent owner CAYMAN CORPORATE CENTRE 27 HOSPITAL ROAD, GEORGE TOWN CAYMAN ISLANDS E9 KY1-9008
Zhengbin Yao director, officer: Chief Executive Officer 10301 STELLA LINK ROAD, HOUSTON TX 77025
William Ragatz officer: VP, Head of Commercial C/O VIELA BIO, INC., ONE MEDIMMUNE WAY FIRST FLOOR, AREA TWO GAITHERSBURG MD 20878